Pictet Asset Management Sa Xenon Pharmaceuticals Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 2,032,730 shares of XENE stock, worth $74.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,032,730
Previous 2,004,297
1.42%
Holding current value
$74.6 Million
Previous $71.7 Million
9.1%
% of portfolio
0.09%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$198 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$159 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$132 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$131 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$117 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.29B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...